Cargando…
Chloroquine and COVID-19: role as a bitter taste receptor agonist?
COVID-19 is a world public health emergency caused by the new coronavirus, SARSCoV-2. Many drugs were repurposed as a treatment for COVID-19 patients including Chloroquine (CQ). CQ is a bitter taste receptor agonist reported to relax the airways suggesting a role in preventing disease severity of CO...
Autores principales: | Bouazza, B., Ramdani, I., Chahed, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830265/ https://www.ncbi.nlm.nih.gov/pubmed/33520251 http://dx.doi.org/10.1016/j.nmni.2021.100843 |
Ejemplares similares
-
Chloroquine: Autophagy inhibitor, antimalarial, bitter taste receptor agonist in fight against COVID-19, a reality check?
por: Sharma, Pawan, et al.
Publicado: (2021) -
Chemoinformatics View on Bitter Taste Receptor Agonists
in Food
por: Bayer, Sebastian, et al.
Publicado: (2021) -
Effects of MP-AzeFlu enhanced by activation of bitter taste receptor TAS2R
por: Ekstedt, Sandra, et al.
Publicado: (2020) -
The influence of bitter-taste receptor (TAS2R) expression in pharmacological response to Chloroquine in obese patients with COVID-19
por: Watanabe, Lígia Moriguchi, et al.
Publicado: (2020) -
Bitter Taste Receptor Agonists Mitigate Features of Allergic Asthma in Mice
por: Sharma, Pawan, et al.
Publicado: (2017)